{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:55:49Z","timestamp":1791615349290,"version":"4.3.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/ja.2017.30","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T02:28:41Z","timestamp":1488335321000},"page":"520-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":395,"title":["The antibiotic resistance crisis, with a focus on the United States"],"prefix":"10.1038","volume":"70","author":[{"given":"Evan","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold L","family":"Demain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"BFja201730_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1271\/bbb.70.1060","volume":"70","author":"H Yoneyama","year":"2006","unstructured":"Yoneyama, H. & Katsumata, R. Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci. Biotechnol. Biochem. 70, 1060\u20131075 (2006).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"BFja201730_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1574-6976.2010.00247.x","volume":"35","author":"S Heeb","year":"2011","unstructured":"Heeb, S. et al. Quinolones: from antibiotics to autoinducers. FEMS Microbiol. Rev. 35, 247\u2013274 (2011).","journal-title":"FEMS Microbiol. Rev."},{"key":"BFja201730_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/nbt1206-1497","volume":"24","author":"P Fernandes","year":"2006","unstructured":"Fernandes, P. Antibacterial discovery and development-the failure of success? Nat. Biotechnol. 24, 1497\u20131503 (2006).","journal-title":"Nat. Biotechnol."},{"key":"BFja201730_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1126\/science.288.5464.287","volume":"288","author":"J Lederberg","year":"2000","unstructured":"Lederberg, J. Pathways of discovery: infectious history. Science 288, 287\u2013293 (2000).","journal-title":"Science"},{"key":"BFja201730_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1263\/jbb.99.485","volume":"99","author":"T Hamaki","year":"2005","unstructured":"Hamaki, T. et al. Isolation of novel bacteria and actinomycetes using soil-extract agar medium. J. Biosci. Bioeng. 99, 485\u2013492 (2005).","journal-title":"J. Biosci. Bioeng."},{"key":"BFja201730_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nbt820","volume":"21","author":"H Ikeda","year":"2003","unstructured":"Ikeda, H. et al. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat. Biotechnol. 21, 526\u2013531 (2003).","journal-title":"Nat. Biotechnol."},{"key":"BFja201730_CR7","unstructured":"Christiansen, K. J. Fusidic acid. Antimicrobe. Available at http:\/\/www.antimicrobe.org\/d29.asp (accessed 23 January 2017)."},{"key":"BFja201730_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.mib.2008.09.009","volume":"11","author":"CN Kraus","year":"2008","unstructured":"Kraus, C. N. Low hanging fruit in infectious disease drug development. Curr. Opin. Microbiol. 11, 434\u2013438 (2008).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFja201730_CR9","first-page":"16","volume":"27","author":"RW Scott","year":"2009","unstructured":"Scott, R. W. Defensin mimetics: nature knows best. Am. Biotechnol. Lab. 27, 16\u201319 (2009).","journal-title":"Am. Biotechnol. Lab."},{"key":"BFja201730_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bcp.2005.10.012","volume":"71","author":"MS Butler","year":"2006","unstructured":"Butler, M. S. & Buss, A. D. Natural products \u2013 the future scaffolds for novel antibiotics? Biochem. Pharmacol. 71, 919\u2013929 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"BFja201730_CR11","unstructured":"Centers for Disease Control and Prevention (CDC) Antibiotic\/antimicrobial resistance. Available at https:\/\/www.cdc.gov\/drugresistance\/ (accessed 23 January 2017)."},{"key":"BFja201730_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/scientificamerican0709-44","volume":"301","author":"CT Walsh","year":"2009","unstructured":"Walsh, C. T. & Fischbach, M. A. Squashing superbugs\u2014the race for new antibiotics. Sci. Am. 301, 44\u201351 (2009).","journal-title":"Sci. Am."},{"key":"BFja201730_CR13","unstructured":"Centers for Disease Control and Prevention (CDC) Methicillin-resistant Staphylococcus aureus (MRSA) \u2013 general information about MRSA in healthcare settings. Available at https:\/\/www.cdc.gov\/mrsa\/healthcare\/index.html#q6 (accessed 24 January 2017)."},{"key":"BFja201730_CR14","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1126\/science.1254163","volume":"345","author":"R Laxminarayan","year":"2014","unstructured":"Laxminarayan, R. Antibiotic effectiveness: balancing conservation against innovation. Science 345, 1299\u20131301 (2014).","journal-title":"Science"},{"key":"BFja201730_CR15","unstructured":"Centers for Disease Control and Prevention (CDC) Biggest threats. Available at https:\/\/www.cdc.gov\/drugresistance\/biggest_threats.html (accessed 24 January 2017)."},{"key":"BFja201730_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.drudis.2014.12.003","volume":"20","author":"ME Ivarsson","year":"2015","unstructured":"Ivarsson, M. E., Leroux, J. C. & Castagner, B. Investigational new treatments for Clostridium difficile infection. Drug Discov. Today 20, 602\u2013608 (2015).","journal-title":"Drug Discov. Today"},{"key":"BFja201730_CR17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bcp.2005.12.016","volume":"71","author":"SB Singh","year":"2006","unstructured":"Singh, S. B. & Barrett, J. F. Empirical antibacterial drug discovery \u2013 foundation in natural products. Biochem. Pharmacol. 71, 1006\u20131015 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"BFja201730_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/sj.embor.7401022","volume":"8","author":"J Davies","year":"2007","unstructured":"Davies, J. Resistance redux. EMBO Rep. 8, 616\u2013621 (2007).","journal-title":"EMBO Rep."},{"key":"BFja201730_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/499394a","volume":"499","author":"M McKenna","year":"2013","unstructured":"McKenna, M. Antibiotic resistance: the last resort. Nature 499, 394\u2013396 (2013).","journal-title":"Nature"},{"key":"BFja201730_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/gen.31.9.24","volume":"31","author":"P Fernandes","year":"2011","unstructured":"Fernandes, P. & Schranz, J. New macrolides essential to treat CABP. J. Gen. Eng. Biotechnol. News 31, 54\u201355 (2011).","journal-title":"J. Gen. Eng. Biotechnol. News"},{"key":"BFja201730_CR21","doi-asserted-by":"crossref","unstructured":"Cain, C. ClpPing Persistence. SciBX 6 (2013).","DOI":"10.1038\/scibx.2013.1338"},{"key":"BFja201730_CR22","unstructured":"The Scientist staff Overcoming resistance. Scientist 28, (2014)."},{"key":"BFja201730_CR23","first-page":"6","volume":"93","author":"B Erickson","year":"2015","unstructured":"Erickson, B. House clears chemicals bill. Chem. Eng. News 93, 6 (2015).","journal-title":"Chem. Eng. News"},{"key":"BFja201730_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nchembio.559","volume":"7","author":"L Ejim","year":"2011","unstructured":"Ejim, L. et al. Combinations of antibiotics and non-antibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7, 348\u2013350 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"BFja201730_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/502S8a","volume":"502","author":"S DeWeerdt","year":"2013","unstructured":"DeWeerdt, S. Vaccines: an age-old problem. Nature 502, 58\u201359 (2013).","journal-title":"Nature"},{"key":"BFja201730_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrd4001","volume":"12","author":"A Zumla","year":"2013","unstructured":"Zumla, A., Nahid, P. & Cole, S. T. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov. 12, 388\u2013404 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFja201730_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/502S4a","volume":"502","author":"A Maxmen","year":"2013","unstructured":"Maxmen, A. Drug development: a combined effort. Nature 502, 54\u201356 (2013).","journal-title":"Nature"},{"key":"BFja201730_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrd4000","volume":"12","author":"T Bjarnsholt","year":"2013","unstructured":"Bjarnsholt, T. et al. Applying insights from biofilm biology to drug development\u2013can a new approach be developed? Nat. Rev. Drug Discov. 12, 781\u2013808 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFja201730_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.drudis.2012.09.007","volume":"18","author":"D Bald","year":"2013","unstructured":"Bald, D. & Koul, A. Advances in discovery of new antibacterials for combating metabolically resting bacteria. Drug Discov. Today 18, 250\u2013255 (2013).","journal-title":"Drug Discov. Today"},{"key":"BFja201730_CR30","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1128\/AAC.00273-12","volume":"56","author":"W Balemans","year":"2012","unstructured":"Balemans, W. et al. Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria. Antimicrob. Agents Chemother. 56, 4131\u20134139 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja201730_CR31","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.1128\/JB.183.23.6746-6751.2001","volume":"183","author":"AL Spoering","year":"2001","unstructured":"Spoering, A. L. & Lewis, K. GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 183, 6746\u20136751 (2001).","journal-title":"J. Bacteriol."},{"key":"BFja201730_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(00)74210-3","volume":"244","author":"JW Bigger","year":"1944","unstructured":"Bigger, J. W. Treatment of staphylococcal infections with penicillin by intermittent sterilization. Lancet 244, 497\u2013500 (1944).","journal-title":"Lancet"},{"key":"BFja201730_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature12790","volume":"503","author":"BP Conlon","year":"2013","unstructured":"Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365\u2013370 (2013).","journal-title":"Nature"},{"key":"BFja201730_CR34","unstructured":"Michel, K. H. & Kastner, R. E. A54556 antibiotics and process for production thereof. US Patent 4492650 (1985)."},{"key":"BFja201730_CR35","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/nm1306","volume":"11","author":"H Broetz-Oesterhelt","year":"2005","unstructured":"Broetz-Oesterhelt, H. et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat. Med. 11, 1082\u20131087 (2005).","journal-title":"Nat. Med."},{"key":"BFja201730_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(16)31079-0","volume":"388","author":"R Laxminarayan","year":"2016","unstructured":"Laxminarayan, R. et al. UN high-level meeting on antimicrobials \u2013 who do we need? Lancet 388, 218\u2013220 (2016).","journal-title":"Lancet"},{"key":"BFja201730_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1359-6446(00)01611-1","volume":"6","author":"J Drews","year":"2001","unstructured":"Drews, J. Quo vadis, biotech? (Part 2). Drug Discov. Today 6, 21\u201326 (2001).","journal-title":"Drug Discov. Today"},{"key":"BFja201730_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/cen-v083n025.p028","volume":"83","author":"AA Daemmrich","year":"2005","unstructured":"Daemmrich, A. A. & Bowden, M. E. A rising drug industry. Chem. Eng. News 83, 28\u201342 (2005).","journal-title":"Chem. Eng. News"},{"key":"BFja201730_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.cbpa.2007.08.012","volume":"11","author":"AL Harvey","year":"2007","unstructured":"Harvey, A. L. Natural products as a screening resource. Curr. Opin. Chem. Biol. 11, 480\u2013484 (2007).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"BFja201730_CR40","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.mib.2005.08.007","volume":"8","author":"JF Barrett","year":"2005","unstructured":"Barrett, J. F. Can biotech deliver new antibiotics? Curr. Opin. Microbiol. 8, 498\u2013503 (2005).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFja201730_CR41","unstructured":"Ernst & YoungThe Ernst & Young Fifteenth Annual Report on the Biotechnology Industry (Ernst & Young LLP, Palo Alto, CA, USA, 2000)."},{"key":"BFja201730_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1021\/cen-v080n004.p027","volume":"80","author":"KJ Watkins","year":"2002","unstructured":"Watkins, K. J. Fighting the clock. Chem. Eng. News 80, 27\u201333 (2002).","journal-title":"Chem. Eng. News"},{"key":"BFja201730_CR43","first-page":"46","volume":"15","author":"GS Burrill","year":"2002","unstructured":"Burrill, G. S. Personalized medicine or block-busterology? BioPharm 15, 46\u201350 (2002).","journal-title":"BioPharm"},{"issue":"suppl 4","key":"BFja201730_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1465-0691.2004.1005.x","volume":"10","author":"K Bush","year":"2004","unstructured":"Bush, K. Antibacterial drug discovery in the 21st century. Clin. Microbiol. Infect. 10 (suppl 4), 10\u201317 (2004).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFja201730_CR45","first-page":"10, 36, 56, 66,","volume":"19","author":"S Fox","year":"1999","unstructured":"Fox, S., Farr-Jones, S. & Yund, M. A. New directions in drug discovery. Gen. Eng. News 19, 10, 36, 56, 66, 80 (1999).","journal-title":"Gen. Eng. News"},{"key":"BFja201730_CR46","first-page":"32","volume":"4","author":"DJ Ausman","year":"2001","unstructured":"Ausman, D. J. Screening\u2019s age of insecurity. Modern Drug Discov. 4, 32\u201334 (2001).","journal-title":"Modern Drug Discov."},{"key":"BFja201730_CR47","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/nbt1201-1099","volume":"19","author":"DF Horrobin","year":"2001","unstructured":"Horrobin, D. F. Realism in drug discovery \u2013 could Cassandra be right? Nat. Biotechnol. 19, 1099\u20131100 (2001).","journal-title":"Nat. Biotechnol."},{"key":"BFja201730_CR48","first-page":"304","volume":"5","author":"DG Kingston","year":"2002","unstructured":"Kingston, D. G. & Newman, D. J. Mother nature\u2019s combinatorial libraries: their influence on the synthesis of drugs. Curr. Opin. Drug Discov. Dev. 5, 304\u2013316 (2002).","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"BFja201730_CR49","first-page":"46","volume":"6","author":"H Waldmann","year":"2002","unstructured":"Waldmann, H. & Breinbauer, R. Nature provides the answer. Screening 6, 46\u201348 (2002).","journal-title":"Screening"},{"key":"BFja201730_CR50","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1021\/jm0704090","volume":"51","author":"DJ Newman","year":"2008","unstructured":"Newman, D. J. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J. Med. Chem. 51, 2589\u20132599 (2008).","journal-title":"J. Med. Chem."},{"key":"BFja201730_CR51","first-page":"275","volume":"70","author":"DM Shlaes","year":"2004","unstructured":"Shlaes, D. M., Projan, S. J. & Edwards, J. E. Jr Antibiotic discovery: state of the state. ASM News 70, 275\u2013281 (2004).","journal-title":"ASM News"},{"key":"BFja201730_CR52","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/sj.bjp.0707432","volume":"152","author":"AR Coates","year":"2007","unstructured":"Coates, A. R. & Hu, Y. Novel approaches to developing new antibiotics for bacterial infections. Br. J. Pharmacol. 152, 1147\u20131154 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"BFja201730_CR53","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.coph.2008.04.008","volume":"8","author":"RH Baltz","year":"2008","unstructured":"Baltz, R. H. Renaissance in antibacterial discovery from actinomycetes. Curr. Opin. Pharmacol. 8, 557\u2013563 (2008).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFja201730_CR54","unstructured":"Cain, C. in: Antibiotic Resistance, SciBx Special Issue on Antibiotic Resistance. 2\u20134 (2013)."},{"key":"BFja201730_CR55","first-page":"282","volume":"70","author":"K Bush","year":"2004","unstructured":"Bush, K. Why it is important to continue antibacterial drug discovery. ASM News 70, 282\u2013287 (2004).","journal-title":"ASM News"},{"key":"BFja201730_CR56","first-page":"1","volume":"8","author":"S Sasidharan","year":"2011","unstructured":"Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K. M. & Yoga, L. L. Extraction, isolation and characterization of bioactive compounds from plants\u2019 extracts. Afr. J. Tradit. Complement. Altern. Med 8, 1\u201310 (2011).","journal-title":"Afr. J. Tradit. Complement. Altern. Med"},{"key":"BFja201730_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tim.2007.03.004","volume":"15","author":"JA Salas","year":"2007","unstructured":"Salas, J. A. & Mendez, C. Engineering the glycosylation of natural products in actinomycetes. Trends Microbiol. 15, 219\u2013232 (2007).","journal-title":"Trends Microbiol."},{"key":"BFja201730_CR58","first-page":"88","volume":"18","author":"BB Pageni","year":"2007","unstructured":"Pageni, B. B. et al. Genetically engineered biosynthesis of macrolide derivatives including 4-amino-4,6-dideoxy-L-glucose from Streptomyces venezuelaeYJ003-OTBP3. J. Microbiol. Biotechnol. 18, 88\u201394 (2007).","journal-title":"J. Microbiol. Biotechnol."},{"key":"BFja201730_CR59","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1574-6976.2008.00124.x","volume":"32","author":"V Kren","year":"2008","unstructured":"Kren, V. & Rezanta, T. Sweet antibiotics \u2013 the role of glycosidic residues in antibiotic and antitumor activity and their randomization. FEMS Microbiol. Rev. 32, 858\u2013889 (2008).","journal-title":"FEMS Microbiol. Rev."},{"key":"BFja201730_CR60","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.bcp.2005.11.025","volume":"71","author":"SD Mills","year":"2006","unstructured":"Mills, S. D. When will the genomics investment pay off for antibacterial discovery? Biochem. Pharmacol. 71, 1096\u20131102 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"BFja201730_CR61","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00253-007-0900-5","volume":"75","author":"H Gross","year":"2007","unstructured":"Gross, H. Strategies to unravel the function of orphan biosynthesis pathways: recent examples and future prospects. Appl. Microbiol. Biotechnol. 75, 267\u2013277 (2007).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"BFja201730_CR62","doi-asserted-by":"publisher","first-page":"10376","DOI":"10.1073\/pnas.0700962104","volume":"104","author":"DW Udwary","year":"2007","unstructured":"Udwary, D. W. et al. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinospora tropica. Proc. Natl Acad. Sci. USA 104, 10376\u201310381 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja201730_CR63","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1021\/mp7001329","volume":"5","author":"H Zhang","year":"2008","unstructured":"Zhang, H., Wang, Y. & Pfeifer, B. A. Bacterial hosts for natural product production. Mol. Pharm. 5, 212\u2013225 (2008).","journal-title":"Mol. Pharm."},{"key":"BFja201730_CR64","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.chembiol.2008.05.010","volume":"15","author":"YM Chiang","year":"2008","unstructured":"Chiang, Y. M. et al. Molecular genetic mining of the Aspergillus secondary metabolome: discovery of the emericellamide biosynthetic pathway. Chem. Biol. 15, 527\u2013532 (2008).","journal-title":"Chem. Biol."},{"key":"BFja201730_CR65","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/cbic.200800389","volume":"10","author":"M Zerkly","year":"2009","unstructured":"Zerkly, M. & Challis, G. L. Strategies for the discovery of new natural products by genome mining. ChemBioChem 10, 625\u2013633 (2009).","journal-title":"ChemBioChem"},{"key":"BFja201730_CR66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nchembio731","volume":"1","author":"S Lautru","year":"2005","unstructured":"Lautru, S., Deeth, R. J., Bailey, L. M. & Challi, G. L. Discovery of a new peptide natural product from Streptomyces coelicolor genome mining. Nat. Chem. Biol. 1, 265\u2013269 (2005).","journal-title":"Nat. Chem. Biol."},{"key":"BFja201730_CR67","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ja.2006.66","volume":"59","author":"DE Cane","year":"2006","unstructured":"Cane, D. E. et al. Geosmin biosynthesis in Streptomyces avermitilis. Molecular cloning, expression and mechanistic study of the germacradienol\/geosmin synthase. J. Antibiot. 59, 471\u2013479 (2006).","journal-title":"J. Antibiot."},{"key":"BFja201730_CR68","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1021\/ja061292s","volume":"128","author":"X Lin","year":"2006","unstructured":"Lin, X., Hopson, R. & Cane, D. E. Genome mining in Streptomyces coelicolor: molecular cloning and characterization of a new sesquiterpene synthase from S. coelicolor. J. Am. Chem. Soc. 128, 6022\u20136023 (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"BFja201730_CR69","doi-asserted-by":"publisher","first-page":"14754","DOI":"10.1021\/ja065247w","volume":"128","author":"L Song","year":"2006","unstructured":"Song, L. et al. Type III polyketide synthase beta-ketoacyl-ACP starter unit and ethylmalonyl-CoA extender unit selectivity discovered by Streptomyces coelicolor genome mining. J. Am. Chem. Soc. 128, 14754\u201314755 (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"BFja201730_CR70","first-page":"121","volume":"44","author":"JH Park","year":"2006","unstructured":"Park, J. H., Cha, C. J. & Roe, J. H. Identification of genes for mycothiol biosynthesis in Streptomyces coelicolor A3. J. Microbiol. 44, 121\u2013125 (2006).","journal-title":"J. Microbiol."},{"key":"BFja201730_CR71","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1099\/mic.0.28335-0","volume":"152","author":"E Busti","year":"2006","unstructured":"Busti, E. et al. Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes. Microbiology 152, 675\u2013683 (2006).","journal-title":"Microbiology"},{"key":"BFja201730_CR72","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/MMBR.68.4.686-691.2004","volume":"68","author":"PD Schloss","year":"2004","unstructured":"Schloss, P. D. & Handelsman, J. Status of the microbial census. Mol. Biol. Rev. 68, 686\u2013691 (2004).","journal-title":"Mol. Biol. Rev."},{"key":"BFja201730_CR73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/mr.59.1.143-169.1995","volume":"59","author":"RI Amann","year":"1995","unstructured":"Amann, R. I., Ludwig, W. & Schleifer, K. H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 59, 143\u2013169 (1995).","journal-title":"Microbiol. Rev."},{"key":"BFja201730_CR74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10531-006-9108-8","volume":"16","author":"GM Mueller","year":"2007","unstructured":"Mueller, G. M. et al. Global diversity and distribution of macrofungi. Biodivers. Conserv. 16, 37\u201348 (2007).","journal-title":"Biodivers. Conserv."},{"key":"BFja201730_CR75","first-page":"333","volume":"3","author":"J Hawksworth","year":"2001","unstructured":"Hawksworth, J. Mushrooms: the extent of the unexplored potential. J. Med. Mushrooms 3, 333\u2013337 (2001).","journal-title":"J. Med. Mushrooms"},{"key":"BFja201730_CR76","first-page":"1","volume":"309","author":"SR Vartoukian","year":"2010","unstructured":"Vartoukian, S. R., Palmer, R. M. & Wade, W. G. Strategies for culture of \u2018unculturable\u2019 bacteria. FEMS Microbiol. Lett. 309, 1\u20137 (2010).","journal-title":"FEMS Microbiol. Lett."},{"key":"BFja201730_CR77","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1462-2920.2009.01949.x","volume":"11","author":"P Hugenholtz","year":"2009","unstructured":"Hugenholtz, P., Hooper, S. D. & Kyrpides, N. C. Focus: synergistetes. Environ. Microbiol. 11, 1327\u20131329 (2009).","journal-title":"Environ. Microbiol."},{"key":"BFja201730_CR78","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nrmicro1161","volume":"3","author":"P Lorenz","year":"2005","unstructured":"Lorenz, P. & Eck, J. Metagenomics and industrial applications. Nat. Rev. Microbiol. 3, 510\u2013516 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFja201730_CR79","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.resmic.2007.12.011","volume":"159","author":"F Lefevre","year":"2008","unstructured":"Lefevre, F. et al. Drugs from hidden bugs: their discovery via untapped resources. Res. Microbiol. 159, 153\u2013161 (2008).","journal-title":"Res. Microbiol."},{"key":"BFja201730_CR80","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00253-009-2233-z","volume":"85","author":"C Simon","year":"2009","unstructured":"Simon, C. & Daniel, R. Achievements and new knowledge unraveled by metagenomic approaches. Appl. Microbiol. Biotechnol. 85, 265\u2013276 (2009).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"BFja201730_CR81","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ja.2013.86","volume":"66","author":"MS Butler","year":"2013","unstructured":"Butler, M. S., Blaskovich, M. A. & Cooper, M. A. Antibiotics in the clinical pipeline in 2013. J. Antibiot. 66, 571\u2013591 (2013).","journal-title":"J. Antibiot."},{"key":"BFja201730_CR82","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.mib.2011.08.002","volume":"14","author":"D Jabes","year":"2011","unstructured":"Jabes, D. The antibiotic R&D pipeline: an update. Curr. Opin. Microbiol. 14, 564\u2013566 (2011).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFja201730_CR83","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nrd3251","volume":"9","author":"R Kneller","year":"2010","unstructured":"Kneller, R. Importance of new companies for drug discovery: origins of a decade of new drugs. Nat. Rev. Drug Discov. 9, 867\u2013882 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFja201730_CR84","unstructured":"U.S. Department of Health & Human Services, Public Health Emergency. Jarrett, E BARDA Broad Spectrum Antimicrobials (BSA) Program. Available at https:\/\/www.phe.gov\/ASPRBlog\/Lists\/Posts\/Post.aspx?ID=97 (accessed 25 January 2017)."},{"key":"BFja201730_CR85","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nbt.2087","volume":"10","author":"JC Reed","year":"2012","unstructured":"Reed, J. C. et al. The NIH\u2019s role in accelerating translational sciences. Nat. Biotechnol. 10, 16\u201319 (2012).","journal-title":"Nat. Biotechnol."},{"key":"BFja201730_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/cen-09047-ad24","volume":"90","author":"LM Jarvis","year":"2012","unstructured":"Jarvis, L. M. NIH initiative aims to partner academics with pharmaceutical companies to revive failed drug candidates. Chem. Eng. News 90, 41\u201343 (2012).","journal-title":"Chem. Eng. News"},{"key":"BFja201730_CR87","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nbt0812-735a","volume":"30","author":"JP Roberts","year":"2012","unstructured":"Roberts, J. P. Incentives aim to boost antibiotic development. Nat. Biotechnol. 30, 735\u2013736 (2012).","journal-title":"Nat. Biotechnol."},{"key":"BFja201730_CR88","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nbt.2572","volume":"31","author":"JL Fox","year":"2013","unstructured":"Fox, J. L. Antimicrobial peptides stage a comeback. Nat. Biotechnol. 31, 379\u2013382 (2013).","journal-title":"Nat. Biotechnol."},{"key":"BFja201730_CR89","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","volume":"11","author":"PD Cotter","year":"2013","unstructured":"Cotter, P. D., Ross, P. & Hill, C. Bacteriocins \u2013 a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95\u2013103 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFja201730_CR90","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nbt.2548","volume":"31","author":"B Olle","year":"2013","unstructured":"Olle, B. Medicines from microbiota. Nat. Biotechnol. 31, 309\u2013315 (2013).","journal-title":"Nat. Biotechnol."},{"key":"BFja201730_CR91","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nbt1113-952b","volume":"31","author":"JL Fox","year":"2013","unstructured":"Fox, J. L. Anti-infective monoclonals step in where antimicrobials fail. Nat. Biotechnol. 31, 952\u2013954 (2013).","journal-title":"Nat. Biotechnol."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja201730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja201730","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ja.2017.30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ja201730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:25:38Z","timestamp":1744136738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFja201730"],"URL":"https:\/\/doi.org\/10.1038\/ja.2017.30","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]},"assertion":[{"value":"1 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}